Erratum: Preclinical Safety and Efficacy of Human CD34+ Cells Transduced with Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (Molecular Therapy (2013) 21 (175-184) DOI:10.1038/mt.2012.23)

Erratum: Preclinical Safety and Efficacy of Human CD34+ Cells Transduced with Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome (Molecular Therapy (2013) 21 (175-184) DOI:10.1038/mt.2012.23) / Scaramuzza, S.; Biasco, L.; Ripamonti, A.; Castiello, M. C.; Loperfido, M.; Draghici, E.; Hernandez, R. J.; Benedicenti, F.; Radrizzani, M.; Salomoni, M.; Ranzani, M.; Bartholomae, C. C.; Vicenzi, E.; Finocchi, A.; Bredius, R.; Bosticardo, M.; Schmidt, M.; Von Kalle, C.; Montini, E.; Biffi, A.; Roncarolo, M. G.; Naldini, L.; Villa, A.; Aiuti, A.. - In: MOLECULAR THERAPY. - ISSN 1525-0016. - 24:6(2016), pp. 1159-1159. [10.1038/mt.2016.96]